BASEL
Switzerland
6
2021-12-09
5
2026-03-17
These are the the leading inventors for applications assigned to NOUSCOM AG:
NOUSCOM AG based in BASEL, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
TELEOST INVARIANT CHAIN CANCER VACCINE
#2 | 2021-11-25 ✅ Patent 11,912,743 granted on 2024-02-27Compositition and uses of teleost invariant chain to enhance T cell response to a vaccine
#3 | 2021-05-06 ✅ Patent 11,098,324 granted on 2021-08-24Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
#4 | 2020-10-01 ✅ Patent 11,643,666 granted on 2023-05-09Eukaryotic cell line
#5 | 2020-07-16 ✅ Patent 11,578,109 granted on 2023-02-14Universal vaccine based on shared tumor neoantigens for prevention and treatment of micro satellite instable (MSI) cancers
#6 | 2019-10-03Herpesvirus with Modified Glycoprotein H for Propagation in a Cell
Also check out NOUSCOM AG's (Basel, Switzerland) applicant profile with 7 patent applications submitted.
170676 ⎘